contact@pleiadestherapeutics.com +91 040-29554225 IDA Jeedimetla, Hyderabad.

Our Products

Pleiades Therapeutics Private Limited


Products

Pleiades Therapeutics will provide Product development services for therapeutic area of Cardiovascular, Diabetology, Gastro-Intestinal, Pain management, Oncology and Autoimmune disorders for global filing.

Anticoagulants (USP and CEP compliance API’s)

S.No. Generic Name of Product US/EU Innovator
1 Ticagrelor tablets, 60 mg and 90 mg Brilliant® and Brilique®
2 Apixaban tablets 5mg and 10 mg Eliquis®
3 Rivaroxaban, 1mg/mL, 2.5 mg, 10 mg, 15 mg and 20 mg Xarelto®
4 Edoxaban tablets, 15mg, 30 mg and 90 mg Savasya® /Lixiana®

Anti-diabetic (USP and CEP compliance API’s)

S.No. Generic Name of Product US/EU Innovator
1 Vildagliptin tablets, 50mg and 100mg Galvus® (EU)
2 Vildagliptin and Metformin tablets, 50mg/500mg and 50mg /1000mg Eucreas® (EU)
3 Sitagliptin tablets, 25mg, 50mg and 100mg Januvia®
4 Sitagliptin and Metformin tablets, 50mg /500mg and 50mg /1000mg Janumet®
5 Dapagliflozin tablets, 5mg and 10mg Forxiga®
6 Dapagliflozin and Metformin tablets, 5mg/1000 mg Xiguo®
7 Linagliptin Tablets 5 mg Trajenta®
8 Linagliptin and Metformin tablets 2.5mg/850mg, 2.5mg/1000 mg Trajenta duo®
9 Empagliflozin tablets, 10mg and 25 mg Jardiance®
10 Empagliflozin and Metformin tablets, 5 mg/500 mg, 5mg/1000mg, 12.5 mg/500 mg and 12.5 mg/1000 mg Synjardy®
11 Sitagliptin/Metformin tablets XR, 50/500, 50/1000 mg and 100/1000mg Janumet XR®
12 Metformin XR Tablets – Reduced pill size, 500mg, 850mg and 1000mg Glucophase XR®
13 Dapagliflozin and Metformin tablets XR, 2.5 mg/1000 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg Xigduo XR®
14 Teneligliptin tablets, 20mg Tenelia®

PPI and GRDDS

S.No. Generic Name of Product US Innovator
1 Pantoprazole Delayed Release Tablets 20 mg, 40 mg Protonix by Wyeth Laboratories
2 Omeprazole Delayed Release Tablets 20 mg Dexcel®
3 Lansoprazole Delayed Release Capsules 15mg, 30mg PREVACID®
4 Esomeprazole magnesium DR Capsules, 20 mg, 40 mg Nexium® 20 mg and 40 mg

Oncology

Hydroxyurea tablets – 100 mg and 1000 mg Other oncology products are under development stage.

Auto-immune disorder

Products are under development.

Pain Management

Products are under development.